Episode 22 with Dr. Paul Matthews discussing the Optimize project in the UK
Links to articles and other resources mentioned in Episode 22:
- FDA Approves Alemtuzumab for MS
- Fatigue: New Mouse Model in the Works
- MSDF Newsletter
- Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci
DOI:
doi/10.7493/msdf.10.27662.1